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Development of a Cosmetic
Procedure Screening
Questionnaire (COPS) for Body
Dysmorphic Disorder
Background
Guidelines recommend screening patients for Body Dys-
morphic Disorder (BDD) prior to cosmetic surgery to
identify those who may require further psychological
assessment1 but there are few validated instruments
available. The aim of the current study was therefore to
develop a screening questionnaire that (a) was brief, free
to download and could identify people with BDD, (b)
might predict either dissatisfaction with a cosmetic
procedure or no change or deterioration in symptoms of
BDD, and (c) may be sensitive to change after an inter-
vention. The new scale was informed by the diagnostic
criteria, expert opinion and a previous study that
compared patients satisfied with cosmetic rhinoplasty
with BDD patients who craved rhinoplasty but had not
been able to obtain it.2
Method
Two groups of participants were recruited:
Community group
We recruited a community group of both genders who were
either planning or very motivated to have a cosmetic
procedure in the future. The questionnaire was completed
by n Z 108 participants.
BDD group
A psychiatrist conducted an interview based on DSM-IV to
diagnose BDD in a clinical setting. Ninety-seven patients
with BDD seeking a cosmetic procedure were recruited.
All participants completed the following:
1) Cosmetic Procedure Screening (COPS) questionnaire
The questionnaire asks for the feature(s) that the
person finds unattractive, the nature of the cosmetic
procedures they are seeking and diagnostic criteria of
BDD. The final version of COPS questionnaire comprises 9
items. Items are scored from 0 (least impaired) to 8
(most impaired). The scale and a full version of this
paper are available to download from: http://www.iop.
kcl.ac.uk/cadatquestionnaire. The score is achieved by
summing Q 2-10. Items 2, 3 and 5 are reversed. The total
ranges from 0 to 72 with a higher score reflecting greater
impairment.
2) Hospital Anxiety and Depression Scale (HAD)
3) Body Image Quality of Life Inventory (BIQLI)
4) Body Image Disturbance Questionnaire (BIDQ)
Results
Items on the COPS that showed a significant difference
between the two groups, which did not have a significant
group  sex interaction and had an effect size (Cohen’s d)
of at least 0.80 were retained in the item discriminatory
analysis. Nine items met these criteria and were used to
form the final questionnaire (see Table 1).
Internal consistency
Reliability analysis resulted in an internal consistency of
Cronbach’s aZ 0.91 with corrected item total ranging from
0.41 to 0.86.
Test-retest reliability
67 participants in the community group repeated the COPS
after 1 week. The COPS had good test-retest reliability
(r Z 0.87, p < 0.01). First administration (M Z 27.94,
SDZ13.89), secondadministration (MZ30.71, SDZ 14.04).
Convergent validity
Based on the data from both groups the COPS correlated
highly with the HAD depression subscale (rZ 0.7, p < 0.01)
and anxiety subscale (r Z 0.66, p < 0.01). COPS also
correlated highly with the BIQLI (rZ - 0.68, p < 0.01). Thus
higher scores on COPS are associated with lower body
image quality of life.
Cut-off value and ROC analysis
Figure 1 represents the ROC curve for BDD patients
compared with community controls. The area under the
curve (AUC) for this analysis was 0.905 (95%
CI Z 0.862e0.948) indicating that the COPS is an accurate
diagnostic test. Based on the discrimination of BDD
patients from the community group, a cut-off value of 40
resulted in a maximal kappa coefficient (k Z 0.69,
p < 0.001). On the basis of this cut-off value, 88.9% of BDD
patients and 80.6% of the community group were classified
correctly.
Sensitivity to change
We examined sensitivity to change in a sub-sample of
5 patients with BDD who were undergoing cognitive
behaviour therapy.3,4 Scores on the COPS were examined
at baseline, 6 weeks, and 12 weeks. The mean and SD on
the 9-item COPS was 52.40 (SD Z 16.70) at baseline and
35.00 (SD Z 22.88) at 12 weeks. A one-way repeated
measures ANOVA was conducted to compare scores across
these 3 treatment points. There was a significant effect
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across the 3 treatment points [F (1.10, 4.38) Z 7.35,
p Z 0.047].
Discussion
We have developed a brief (nine item) screening ques-
tionnaire (COPS) that can be used in a cosmetic procedure
setting to screen patients with BDD. The scale has
acceptable internal consistency, test-retest reliability, and
convergent validity. It has a high sensitivity for the
diagnosis of BDD in people who are likely to seek
a cosmetic procedure. Individuals who score 40 or more
should be referred for further assessment. The COPS was
also sensitive to change in patients receiving cognitive
behaviour therapy.3,4 It may therefore be used an outcome
measure after any treatment (including cosmetic proce-
dures) to determine (a) if there is any improvement in
symptoms of BDD on a continuous dimension (b) whether it
may predict persistence of symptoms or dissatisfaction
with a cosmetic procedure (in the absence of any surgical
complications).
Table 1 Difference between the community group and BDD group, effect size and group  sex interaction for all items (items
in bold were retained for use in the final questionnaire).
Variable Community
group
BDD
Group
Difference
between
Groups
Effect
Size (d)
Group  Sex
interaction
M (SD) M (SD) U value p value p value
1. Avoid looking at my
feature(s)
3.32 (2.71) 3.00 (2.62) 4346.5 0.615 ns 0.12 Men: >0.05 ns
Women: >0.05 ns
2. Frequency of checking
feature(s)
2.82 (2.05) 5.15 (1.66) 2891 <0.001 1.25 Men:<0.01
Women:<0.001
3. How ugly, unattractive
or ’not right’
feature(s) are
4.83 (2.19) 7.15 (1.60) 2615.5 <0.001 1.22 Men:<0.001
Women:<0.001
4. Distress caused by
feature(s)
3.92 (2.27) 7.05 (1.1) 1640 <0.001 1.84 Men:<0.001
Women:<0.001
5. Avoid situations or
activities because of
feature(s)
2.64 (2.43) 5.95 (1.9) 2609 <0.001 1.53 Men:<0.01
Women:<0.001
6. Preoccupation with
feature(s)
3.28 (2.14) 7.15 (1.27) 993 <0.001 2.26 Men:<0.001
Women:<0.001
7. Interference with
relationship/dating
3.10 (2.74) 6.25 (1.62) 2008 <0.001 1.79 Men:<0.001
Women:<0.001
8. Interference with
sexual relationship
2.68 (2.74) 3.7 (3.13) 2257 <0.001 0.35 Men: <0.05
Women: <0.001
9. Inability to work/study
due to feature(s)
1.32 (4.22) 5.25 (1.86) 1231 <0.001 0.83 Men:<0.001
Women:<0.001
10. Interference with
social life
2.42 (2.4) 6.2 (1.77) 1301.5 <0.001 1.8 Men:<0.001
Women:<0.001
11. Noticeability of
feature(s) to other
people
4.74 (2.43) 5.95 (2.28) 3067.5 <0.001 0.51 Men: <0.01
Women: <0.001
12. Frequency of
comparing feature(s) to
other people
4.33 (1.7) 6.2 (1.32) 1606.5 <0.001 0.62 Men: <0.001
Women: <0.001
13. Trying to please self or
others by having
procedure
6.44 (1.53) 7.35 (0.93) 2251 <0.001 0.74 Men: <0.01
Women: <0.01
14. Amount of
discouragement from
having procedure
4.03 (2.8) 3.7 (2.9) 2405 0.54 ns 0.11 Men: >0.05 ns
Women: >0.05 ns
15. Understanding from
family/friends about
feature(s)
4.3 (2.47) 4.92 (2.50) 3064 0.086 ns 0.25 Men: >0.05 ns
Women: >0.05 ns
16. Importance of
appearance in
defining who you are
3.77 (1.79) 5.65 (1.97) 1900.5 <0.001 0.96 Men:<0.001
Women:<0.001
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Do patients undergoing minor local
anaesthetic plastic surgery
procedures really need an MRSA
swab?*
Introduction
As patients with Meticillin-resistant Staphylococcus aureus
(MRSA) colonisation are at risk of subsequent infection, pre-
morbid identification and decolonisation should reduce
infection and transmission.1 Therefore, the Department of
Health in England introduced screening of all elective
patients for MRSA in a 2009 working framework, suggesting
this may be cost-effective.2 The original guidance made
certain clear exceptions, including minor dermatology,
commenting that MRSA infection rates were sufficiently low
to negate cost economy.
Plastic surgery at our hospital is limited to local anaes-
thetic day case procedures; complex cases or those
requiring general anaesthesia are treated at a regional
centre. Typical patients include benign and malignant skin
excisions with direct wound closure, or utilising local flaps
or skin grafts. MRSA screening of elective patients (nose,
throat, axilla and groin) was introduced in 2009 as this
speciality was not explicitly exempt. As a practical and
Figure 1 Receiver operating characteristics plot of COPS
scores of BDD patients compared with community controls.
* This study has not been published or presented elsewhere.
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